compound 2-2c [PMID: 32003560]   Click here for help

GtoPdb Ligand ID: 10689

PDB Ligand
Compound class: Synthetic organic
Comment: Compound 2-2c is a selective inhibitor of DYRK1A whose chemical structure is derived from that of the DYRK1 kinase inhibitor harmine [1]. It was developed for potential to promote pancreatic β-cell proliferation as a novel mechanism to be applied to the treatment of type 1 diabetes. It produces predicted effects on β-cells in vitro and in vivo.
See also GNF2133, which is a selective DYRK1A inhibitor with a different chemical scaffold [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 5
Topological polar surface area 70.14
Molecular weight 297.15
XLogP 1.98
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES COc1ccc2c(c1)n(CCCC(=O)N)c1c2ccnc1C
Isomeric SMILES COc1ccc2c(c1)n(CCCC(=O)N)c1c2ccnc1C
InChI InChI=1S/C17H19N3O2/c1-11-17-14(7-8-19-11)13-6-5-12(22-2)10-15(13)20(17)9-3-4-16(18)21/h5-8,10H,3-4,9H2,1-2H3,(H2,18,21)
InChI Key MRZRJTZGNFPMNY-UHFFFAOYSA-N
Bioactivity Comments
Compound has an improved kinase selectivity profile compared to harmine [1] as determined using the DiscoverX KINOMEscan platform. In this screen, in addition to DYRK1A, 10 μM 2-2c strongly inhibited (by >90%) CLK1, CLK2, DYRK1B, DYRK2, HASPIN, HIPK2 and PIK4CB (PI4KB). 2-2c cannot cross the blood-brain-barrier, and in any event has low activity across a range of known harmine off-targets. Harmine is known to inhibit MAO-A, and 2-2c retains this activity (both compounds inhibit MAO-A by ≥95%).
Selectivity at enzymes
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
dual specificity tyrosine phosphorylation regulated kinase 1A Hs Inhibitor Inhibition 7.6 pIC50 - 1
pIC50 7.6 (IC50 2.5x10-8 M) [1]